EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Do benzodiazepines reduce the efficacy of transcranial magnetic stimulation?

Lana Tran, Lisa Hahn, Shane Gill, Felicity Ng, Patrick Clarke, Tom Paterson, Cherrie Galletly iD

Australasian Psychiatry · 2024

DOI: 10.1177/10398562241229623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australasian Psychiatry, 2024. Verfasst von Lana Tran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatry Trainee, School of Medicine, Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Benzodiazepines, Major Depressive Disorder, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the effect of concomitant use of benzodiazepines on the efficacy of repetitive transcranial magnetic stimulation (rTMS) in patients with treatment-resistant major depressive disorder (TR-MDD).

Methods

This is a retrospective study comparing rTMS treatment outcomes between patients taking benzodiazepines ( n = 59) and those who were not ( n = 136). Participants completed the HAM-A, HAM-D17, MADRS and ZUNG at baseline and at the end of treatment.

Results

Patients taking benzodiazepines during rTMS treatment did not show any difference in partial response, response or remission rates compared to patients not treated with benzodiazepines. There was a significant decrease ( p < .0001) in depression and anxiety scores from baseline to post-treatment among both groups.

Conclusions

Concomitant benzodiazepine treatment had no effect on the efficacy of rTMS treatment of TRD, contrary to previous research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcranial Magnetic StimulationBenzodiazepinesMajor Depressive DisorderDepressive Disorder, Treatment-ResistantHumansMaleFemaleAdultRetrospective StudiesMiddle AgedTreatment OutcomeCombined Modality Therapy

Stichwörter der Autor:innen

Major depressive disorderbenzodiazepinetranscranial magnetic stimulationtreatment resistant

Substanzen

Benzodiazepines

Autor:innen und Institutionen

  • Psychiatry Trainee, School of Medicine, Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia.
  • Research Officer, Ramsay Clinic Adelaide, Ramsay Health Care (SA) Mental Health Services, Adelaide, SA, Australia.
  • Consultant Psychiatrist, Ramsay Clinic Adelaide, Ramsay Health Care (SA) Mental Health Services, Adelaide, SA, Australia; Director of Psychiatry Training, Adelaide, SA, Australia; and School of Medicine, Discipline of P…
  • Consultant Psychiatrist, School of Medicine, Discipline of Psychiatry, University of Adelaide; and Ramsay Clinic Adelaide, Ramsay Health Care (SA) Mental Health Services, Adelaide, SA, Australia.
  • Emerita Professor, School of Medicine, Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia; and Consultant Psychiatrist, Northern Adelaide Local Health Network, Adelaide, SA, Australia.

ORCID-Profile: Cherrie Galletly

Zitieren

APA

Tran, L., Hahn, L., Gill, S., Ng, F., Clarke, P., Paterson, T., & Galletly, C. (2024). Do benzodiazepines reduce the efficacy of transcranial magnetic stimulation?. Australasian Psychiatry. https://doi.org/10.1177/10398562241229623

Vancouver

Tran L, Hahn L, Gill S, Ng F, Clarke P, Paterson T, et al. Do benzodiazepines reduce the efficacy of transcranial magnetic stimulation?. Australasian Psychiatry. 2024. doi:10.1177/10398562241229623

BibTeX
@article{Tran2024,
  author = {Tran, Lana and Hahn, Lisa and Gill, Shane and Ng, Felicity and Clarke, Patrick and Paterson, Tom and Galletly, Cherrie},
  title = {Do benzodiazepines reduce the efficacy of transcranial magnetic stimulation?},
  journal = {Australasian Psychiatry},
  year = {2024},
  doi = {10.1177/10398562241229623}
}
Kostenlos starten →